glp 1 for research Glucagon-like peptide-1 receptor: mechanisms and advances in therapy The GLP-1 family, explained for

10.1016/j.molmet.2021.101296 69 MetzlerM.Legendre-GuilleminV.GanL.ChopraV.KwokA.McPhersonP

Holst 2024)

Typically, GLP-1 medications are considered for individuals with a BMI of 30 or greater, which categorizes them as obese

Protein Your Most Critical Supplement on GLP-1 Why it matters: When you lose weight, whether from diet, medication, or any other cause, your body loses both fat and muscle

doi: 10.1042/CS20110374 37 DarsaliaV.HuaS.LarssonM.MallardC.NathansonD.NystromT.et al

Common side effects include nausea, fullness, mild digestive changes, or decreased appetite that feels unusually strong during early treatment